Sutro Biopharma, Inc.
Sutro Biopharma, Inc. is dedicated to the discovery and development of precisely designed cancer therapeutics, transforming science into solutions for patients. The company focuses on next-generation cancer therapeutics, including antibody drug conjugates (ADCs), and employs fit-for-purpose technology such as cell-free XpressCF® to broaden patient benefit and improve patient experience. Sutro is committed to diversity, equity, inclusion, and belonging (DEIB), supporting community and sustainability efforts, and maintaining high standards of integrity and collaboration. The company is also involved in innovative research collaborations, including projects like Project Stella for pediatric AML immunotherapies and partnerships with Fred Hutchinson Cancer Center.
Industries
Nr. of Employees
large (251-1000)
Sutro Biopharma, Inc.
South San Francisco, California, United States, North America
Products
Luveltamab Tazevibulin (luvelta)
A folate receptor alpha-targeting ADC in clinical studies for the treatment of platinum-resistant ovarian cancer.
STRO-003
A ROR1-targeting ADC under a global licensing agreement, with potential milestone payments and royalties on sales.
STRO-004
A tissue factor-targeting ADC planned for IND submission in 2025.
XpressCF®
Cell-free protein synthesis technology used for broader patient benefit and improved patient experience.
Environmental Sustainability Initiatives
Includes efforts to minimize environmental footprint through waste reduction, energy-efficient design, and sustainable operations.
Summer Internship Program
Opportunity for students to gain experience and develop skills in the biopharma industry.
Luveltamab Tazevibulin (luvelta)
A folate receptor alpha-targeting ADC in clinical studies for the treatment of platinum-resistant ovarian cancer.
STRO-003
A ROR1-targeting ADC under a global licensing agreement, with potential milestone payments and royalties on sales.
STRO-004
A tissue factor-targeting ADC planned for IND submission in 2025.
XpressCF®
Cell-free protein synthesis technology used for broader patient benefit and improved patient experience.
Environmental Sustainability Initiatives
Includes efforts to minimize environmental footprint through waste reduction, energy-efficient design, and sustainable operations.
Summer Internship Program
Opportunity for students to gain experience and develop skills in the biopharma industry.
Services
Compassionate Use / Expanded Access Assessment
Evaluation of individual patient requests for investigational medicines according to eligibility criteria, safety considerations, and regulatory requirements.
Clinical Trial Operations Support
Operational management and coordination with clinical sites to monitor enrollment, manage investigational product supply, and mitigate disruptions.
Clinical-scale Manufacturing and Supply Chain Management
Internal manufacture of clinical materials combined with coordination of third-party manufacturing partners and suppliers to support clinical programs.
Analytical Development and Quality Control Services
Development of analytical methods and quality control testing to support product characterization and release for clinical studies.
Preclinical Collaboration and Research Partnerships
Collaborative research with academic centers for early-stage target identification and preclinical development.
Regulatory Affairs and Safety Reporting Support
Management of regulatory interactions, IRB requirements, and safety reporting processes for investigational product use and clinical programs.
Compassionate Use / Expanded Access Assessment
Evaluation of individual patient requests for investigational medicines according to eligibility criteria, safety considerations, and regulatory requirements.
Clinical Trial Operations Support
Operational management and coordination with clinical sites to monitor enrollment, manage investigational product supply, and mitigate disruptions.
Clinical-scale Manufacturing and Supply Chain Management
Internal manufacture of clinical materials combined with coordination of third-party manufacturing partners and suppliers to support clinical programs.
Analytical Development and Quality Control Services
Development of analytical methods and quality control testing to support product characterization and release for clinical studies.
Preclinical Collaboration and Research Partnerships
Collaborative research with academic centers for early-stage target identification and preclinical development.
Regulatory Affairs and Safety Reporting Support
Management of regulatory interactions, IRB requirements, and safety reporting processes for investigational product use and clinical programs.
Expertise Areas
- Cell-free protein expression
- Antibody-drug conjugate development
- Clinical trial management
- Clinical-scale manufacturing and MSAT
Key Technologies
- Cell-free protein synthesis
- Site-specific antibody–drug conjugation
- Clinical-scale biologics manufacturing
- Analytical assay development